Benjamin Rodriguez, PA
Physician Assistant · Union Gap, WANPI 1588998645
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,114 of the $7,293 with a category attached, or 83.8%. 42 manufacturers reported payments, led by Tandem Diabetes Care, Inc. at 25.5% of the total. Reporting peaked in 2024 at $3,036 and has fallen 57.2% since, to $1,299 in 2025. Among physician assistant clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 310 payments — averaging $23.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tandem Diabetes Care, Inc.$2K
- Novo Nordisk$958
- Boehringer Ingelheim$541
- AstraZeneca$365
- Lilly USA, LLC$346
- Abbott$344
- plus $3K from 36 others
What the payments were for
- Travel & lodging$1,16716%
- Food & beverage$6,11484%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,293 in reported general payments places this provider in the 95th percentile of 2,741 physician assistant providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 224 | $304,153 |
| JardianceEmpagliflozin | 130 | $153,324 |
| TrulicityDulaglutide | 95 | $115,975 |
| FarxigaDapagliflozin Propanediol | 73 | $82,010 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 51 | $69,550 |
| MounjaroTirzepatide | 60 | $63,620 |
| Tresiba Flextouch U-200Insulin Degludec | 42 | $51,755 |
| Humalog Kwikpen U-200Insulin Lispro | 26 | $47,405 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 37 | $41,574 |
| Humalog Kwikpen U-100Insulin Lispro | 145 | $40,223 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 219 | $32,986 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 28 | $30,726 |
| HumalogInsulin Lispro | 94 | $26,763 |
| FiaspInsulin Aspart (Niacinamide) | 12 | $19,358 |
| JanuviaSitagliptin Phosphate | 17 | $17,504 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Fiasp, Novolog | $958 | $334,283272 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog, Humulin 70-30 | $346 | $207,314268 claims |
| Boehringer IngelheimJardiance | $541 | $153,324130 claims |
| AstraZenecaFarxiga | $365 | $82,01073 claims |
| Sanofi-aventis U.S. LLCLantus | $288 | $5,21123 claims |
| AbbVieSynthroid | $99 | $1,95035 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,741 physician assistant providers in Washington.
Other physician assistant in Union Gap
- Jill KandoraShoreline$437K
- Jeannette HartRichland$263K
- Lance KeckTacoma$162K
- Erinn KingSeattle$129K
- Christy VathSeattle$75K
- Scott TaylorMercer Island$71K
- Gina FragioneGraham$69K
- Regan BrownSpokane$56K
- Justin ChapinSeattle$40K
- Susan DuffyBellevue$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.